Related Experiment Videos
Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias
1Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Abstract:
Human myeloid cell nuclear differentiating antigen (MNDA) is a Mr 55,000 non-histone basic nuclear protein expressed in myeloid leukemia cell lines that are at late stages of differentiation (HL-60 and U937) and in normal granulocytes and monocytes, but is not present in lymphoid cells or in other human cells and tissues tested. Affinity purified monospecific polyclonal antibodies and rat monoclonal antibodies have been developed for the immunocytochemical detection of MNDA. Using these antibodies, we surveyed 21 cases of acute leukemia classified by French-American-British (FAB) Group criteria, two cases of biphenotypic acute leukemia and one case of blast crisis of chronic granulocytic leukemia for the presence of MNDA. The most intense staining reactions were present in the nuclei of two cases of acute promyelocytic (FAB M3) leukemia. MNDA was not detected in three of five cases of acute myeloblastic leukemia without maturation (FAB M1). The remaining two cases of the M1 category showed weak to moderate staining. No staining reaction was seen in acute lymphocytic leukemia (ALL), biphenotypic leukemia or the lymphoid blast crisis of chronic granulocytic leukemia. Variable staining reactions were demonstrated in the remaining cases. These data suggest that the presence of MNDA is correlated with myeloid and monocytic differentiation in acute leukemia, being strongly expressed in M3 type, often not detected in M1 leukemia and absent in ALL.
Insights
Human myeloid cell nuclear differentiating antigen (MNDA) is a nuclear protein found in myeloid leukemia cells and normal granulocytes. Its presence correlates with myeloid and monocytic differentiation, being strongly expressed in M3 leukemia and absent in ALL.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Human myeloid cell nuclear differentiating antigen (MNDA) is a nuclear protein.
- MNDA is expressed in differentiated myeloid cells like granulocytes and monocytes.
- It is absent in lymphoid cells and other human tissues.
Purpose of the Study:
- To investigate the expression of MNDA in various types of acute leukemia.
- To determine if MNDA expression correlates with myeloid or monocytic differentiation.
- To assess MNDA as a potential diagnostic marker in leukemia classification.
Main Methods:
- Development of affinity-purified polyclonal and monoclonal antibodies for MNDA detection.
- Immunocytochemical analysis of MNDA presence in 21 acute leukemia cases (FAB classification).
- Evaluation of MNDA expression in biphenotypic leukemia and chronic granulocytic leukemia blast crisis.
Main Results:
- Intense MNDA staining observed in acute promyelocytic leukemia (FAB M3).
- MNDA was not detected or weakly expressed in acute myeloblastic leukemia without maturation (FAB M1).
- No MNDA staining was found in acute lymphocytic leukemia (ALL) or lymphoid blast crisis.
Conclusions:
- MNDA expression is significantly correlated with myeloid and monocytic differentiation in acute leukemia.
- MNDA shows strong expression in M3 leukemia and is absent in ALL, suggesting diagnostic utility.
- MNDA can serve as a marker to distinguish myeloid/monocytic leukemias from lymphoid leukemias.